Font Size: a A A
Keyword [Parkinson’s Disease]
Result: 41 - 60 | Page: 3 of 10
41. Regulatory Effect And Underlying Mechanisms Of Autophagy On Age-Related Sensitivity To Parkinson’s Disease Onset
42. The Mechanisms Of6-OHDA-induced Neurotoxicity In PC12Cells And Establishment Of The Model Of Parkinson’s Disease With Depression
43. Deficiency Of Aquaporin4Results In Low Level Of TGF-beta In Midbrain And Severe Parkinson’s Disease
44. Mechanistic Study Of The Neuroprotective Effects Of Squamosamide Derivative FLZ
45. Conversion Of Human Umbilical Cord Mesenchymal Stem Cells In Wharton’s Jelly To Dopamine Neurons Mediated By The Lmx1a And Neurturin In Vitro:Potential Therapeutic Application For Parkinson’s Disease In A Rhesus Monkey Model
46. Clinical Trial On Parkinson’s Disease Treated By "the Seven Acupoints Of The Cranial Base"
47. Imaging Marker Of Early Parkinson’s Disease Based On Multimodal MR Imaging And Computer Aided Diagnosis
48. Substance P Of Mpp ~ + Induced Mes23.5 Protective Effect And Mechanism Of Apoptosis
49. Complementing The Hepatorenal The Curative Effect Of Complex Treatment Of Parkinson's Disease And Bowel Dysfunction
50. High-frequency Stimulation Of The Ventromedial Thalamic Nucleus Improves Motor Signs In Hemiparkinsonian Rats
51. The Effect Of Beta-asarone On The6-OHDA Induced Rats Via Modulating Autophagy
52. The Protection Of Pabing â…¡ Formula In Nigral Dopaminergic Neuronal Of Rat Model Of Parkinson’s Disease
53. Isolation And Identification Of Serum Exosomes And The Relationship Between Exosomal Proteins And Parkinson’s Disease
54. GRIN2B、SLC6A3、SLC18A2Gene Polymorphisms Associated With The Development Of Dyskinesia In Parkinson’s Disease
55. Long-acting Non-ergot Dopamineagonists In Parkinson’s Disease: A Systematic Reviewand Meta-analysis Of Randomized Controlled Trials
56. A Study On The Protective Mechanisms Of GDNF-NCAM Signaling Pathway Being Involved In The Protective Effect On DA Neural Cells
57. MEF2D And Degradation By Chaperone-mediated Autophagy In Parkinson’s Disease
58. The Molecular Mechanism On Thioredoxin1Suppressing Endoplasmic Reticulum Stress In Environmental Toxicant MPTP Model Of Parkinson’s Disease
59. Cognitive Impairment And Genetic Susceptibility In Parkinson’s Disease
60. Effects Of Aging On Brain Iron Homeostasis And Protein Aggregation:Focus On Parkinson’s Disease And Alzheimer’s Disease
  <<First  <Prev  Next>  Last>>  Jump to